Skip to main content
ConductScienceScienceDex

Stavroula Kousteni

NIH Rank #4145
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Early Career
  • Mentor
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 7752388Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Physiology

NIH Funding · FY2025

Linked Award Amount
$2.7M
Full award amounts, FY2025
Award Records
6
Records listing this PI
Award-Linked Rank
#4,145
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Stavroula Kousteni. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Stavroula Kousteni as a PI. Multi-PI records show the full award amount for context.

  • 2P01AG032959-16A1P01
    Bone as a Target and a Regulator of Aging
    Columbia University
    $626.1K
    award amount
  • 5R01AG083081-02R01
    Epigenetic deregulation of osteoblasts promotes age related clonality in hematopoietic cells 
    Columbia University
    $616.1K
    award amount
  • 5R01AG080142-03R01
    Molecular Mechanisms of MDS pathogenesis with aging
    Columbia University
    $490K
    award amount
  • 5P01CA285250-02P01
    Aging-related hematopoietic stem cell intrinsic and microenvironmental signals in AML transformation
    Columbia University
    $374.7K
    award amount
  • 5R01AR077152-05R01
    Cellular and Molecular mechanisms of ATRA inhibition of osteoblast-induced MDS development
    Columbia University
    $301.5K
    award amount
  • 5T32DK007328-45T32
    Hormones: Molecular Mechanism of Action and Functions
    Columbia University
    $269.5K
    award amount

Award organization

Organizations that administered FY2025 awards listing Stavroula Kousteni as a PI.

FY2025 award administered by Columbia University (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Columbia University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3136
  6. 2024
    Entered Top 25% Nationally
    Ranked #3136
  7. 2025
    $5M Cumulative Funding
  8. 2025
    R01 Grant Holder
  9. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Stavroula Kousteni.

Gerard Karsenty
Columbia University
3
shared awards
Lori M Zeltser
Columbia University
3
shared awards
Patricia Florence Ducy
Columbia University
3
shared awards
Emmanuelle Passegue
Columbia University
2
shared awards
Peter Alan Sims
Columbia University
2
shared awards
Raul Rabadan
Columbia University
2
shared awards
Ulrich Steidl
Columbia University
2
shared awards

Explore further

Find collaborators for Stavroula Kousteni

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →